Observatorio de I+D+i UPM

Memorias de investigación
Research Publications in journals:
Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results
Year:2018
Research Areas
  • Electronic technology and of the communications
Information
Abstract
An ongoing clinical trial is testing the efficacy ofweb telematic support in a structured programfor obesity treatment and diabetes prevention. Participantswere recruited fromtwotertiary-care hospitals and randomized to receive either a telematic intervention (TI) supported by PREDIRCAM2 web platform or a non-telematic intervention (NTI). All receive 1-year follow-up. Both interventions consist of tailored dietary and exercise prescriptions, based on a Mediterranean dietary pattern and generalWHOexercise recommendations for adults.At 6months, both groups have received 7 contacts, 3 exclusively telematic for the TI group. This is a preliminary result intention-to-treat analysis. One hundred eighty-three participants were recruited, with a mean body mass index of 34.75 ? 2.75 kg/m2. General dropout rate at 6 months was 26.8%. Weight changes were statistically significant at months 3 and 6 compared to baseline, -2.915 ? 0.24 kg, -3.29 ? 0.36 kg, respectively (P < 0.001), but not statistically significant between the 3- and 6-month time points -0.37 ? 0.21 kg (P= 0.24). Mean group differences showed that the TI group lost 1.61 ? 1.88 kg more than the NTI group (P= 0.39). Waist, waist/hip ratio, resting heart rate, blood pressure, HbA1c, and low-density lipoprotein cholesterol also showed statistically significant changes at 6months, with no significant differences between groups.Weight loss in the TI group shows similar results as the usual care NTI group for weight loss and control of obesity comorbidities.At completion of the clinical trial, these resultswill be reevaluated to assess the potential role of web support in weight-loss maintenance and its cost-effectiveness.
International
Si
JCR
Si
Title
Diabetes Technology & Therapeutics
ISBN
1520-9156
Impact factor JCR
2,921
Impact info
Volume
20
10.1089/dia.2017.0456
Journal number
5
From page
380
To page
385
Month
SIN MES
Ranking
Participants
  • Autor: Maria Elena Hernando Perez (UPM)
  • Autor: Jose Manuel Iniesta Chamorro (UPM)
Research Group, Departaments and Institutes related
  • Creador: Grupo de Investigación: Grupo de Bioingeniería y Telemedicina
  • Centro o Instituto I+D+i: Centro de tecnología Biomédica CTB
  • Departamento: Tecnología Fotónica y Bioingeniería
S2i 2020 Observatorio de investigación @ UPM con la colaboración del Consejo Social UPM
Cofinanciación del MINECO en el marco del Programa INNCIDE 2011 (OTR-2011-0236)
Cofinanciación del MINECO en el marco del Programa INNPACTO (IPT-020000-2010-22)